key: cord-0887322-uh92q995
authors: Galougahi, Mahboobeh Karimi; Ghorbani, Jahangir; Bakhshayeshkaram, Mehrdad; Naeini, Ali Safavi; Haseli, Sara
title: Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report
date: 2020-04-11
journal: Acad Radiol
DOI: 10.1016/j.acra.2020.04.002
sha: 57d91335ba52c2f6e67e0d7236d18e748db7af57
doc_id: 887322
cord_uid: uh92q995

nan

Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report Since the initial reports of the novel coronavirus disease (COVID-19) in December 2019 in Wuhan, China, and the declaration by the World Health Organization of the disease as a pandemic, increasing numbers of patients are diagnosed with COVID-19 globally on a daily basis. While initially fever, cough and dyspnea were thought to be the dominant symptoms, other unusual presentations of COVID-19 such as altered olfactory function have been increasingly recognized. Recently, isolated anosmia/hyposmia is reported as a marker of COVID-19. The onset of anosmia was sudden in majority of the cases and most had a concomitant decrease in taste sensation (1) .

Postviral anosmia is the most common underlying cause of anosmia, accounting for up to 40% of the cases (2). The underlying cause is primarily mucosal congestion, which leads to nasal obstruction and conductive olfactory loss (2) . While anosmia in the majority of cases resolves once the clinical symptoms and obstruction subside, some patients are left with permanent anosmia due to virus-induced sensory neuronal damage known as postviral olfactory loss (3) . The pathogenesis of severe acute respiratory syndrome (SARS)-CoV-2induced anosmia is not fully understood. Nonetheless, cellular factors for SARS-CoV-2 entry (i.e. angiotensin converting enzyme 2 receptor and transmembrane serine protease 2) are expressed in the olfactory epithelium and not in the olfactory sensory neurons, indicating olfactory epithelium as the putative entry site of SARS-CoV-2 (4).

Olfactory bulb (OB) magnetic resonance imaging (MRI) is useful for evaluation of patients with anosmia/hyposmia as it allows for examination of the anatomic details, while T1-or T2-weighted images alone or in more advanced sequences such as magnetization-prepared rapid gradient echo sequence (5, 8) . The main MRI finding in anosmia secondary to upper respiratory infection or trauma is reduced olfactory bulb and tract volume, which correlates with the olfactory function (5) .

OB MRI has not been used yet for evaluation of anosmia in COVID-19. Herein we present the first report of the findings on OB MRI in a patient presenting with isolated anosmia secondary to COVID-19 that was confirmed by the polymerase chain reaction assay. Despite the sudden onset of a complete loss of olfactory function, we found normal OB volume without abnormal signal intensity in the OB and tract and no sign of nasal congestion (Fig 1) . This finding is consistent with prior reports in 2002-2003 of SARS-CoV-induced anosmia, where OB MRI similarly did not demonstrate abnormal findings (6) .

Although the findings on MRI of the olfactory tract were normal in our patient, using hybrid imaging such as singlephoton emission computed tomography-MRI with nasal thalium-201 that allows for examination of the olfactory nerve connectivity in patients with impaired olfaction (7) . Or additional sequences in the MRI protocol such as magnetization-prepared rapid gradient echo sequence which is the sequence that captures high tissue contrast and provides high spatial resolution with whole brain coverage in a short scan time will be useful for detection of abnormalities that SARS-CoV-2 may cause in the olfactory system (8) . Furthermore, our imaging was performed in the early phase of COVID-19 only. We suggest future studies in patients with isolated anosmia secondary to COVID-19 to perform OB MRI longitudinally both in the acute phase and in follow-up to assess for possible temporal evolution of the imaging findings.

No. 

Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients

Olfactory disorders following upper respiratory tract infections. Taste and Smell

Postviral olfactory loss

Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak

Clinical image: olfactory bulb and tract Aplasia/ Hypoplasia on MRI

Olfactory neuropathy in severe acute respiratory syndrome: report of a case

Evaluation of the olfactory nerve transport function by SPECT-MRI fusion image with nasal thallium-201 administration

MRI detection of olfactory bulb and tract